Conditions: Attention Deficit Hyperactivity Disorder
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 267
Healthy volunteers: no

Brief summary:
The primary purpose of the study is to assess long-term safety and tolerability of Edivoxetine in pediatric participants with attention deficit hyperactive disorder (ADHD).

Detailed description:

Arms:
arm 1: All enrolled participants were administered starting dose of 0.1 milligram per kilogram per day (mg/kg/day), or participant specific known stable dose, rollover participants (LNBJ \[No NCT number\]) and (LNBF \[NCT00922636\]), up to 0.3 mg/kg/day, oral, daily for up to 5 years.

Interventions: intervention 1: Edivoxetine
Intervention descriptions: intervention 1: 0.1 mg/kg/day or participant specific known stable dose, rollover participants (LNBJ \[No NCT number\]) and (LNBF \[NCT00922636\]), up to 0.3 mg/kg/day, oral, daily for up to 5 years.

Protocol document: